Upcoming Medical Conferences in IllinoisSearch Criteria : United States of America
Adult-Gerontology Acute Care Nurse Practitioners (AGACNP) Course by Barkley & Associates, Inc. (May 25 - 26, 2019)
May 25 - 26, 2019 | CECH 16.25 | USD $599 | Chicago, Illinois
Adult-Gerontology Acute Care Nurse Practitioners (AGACNP) Course is organized by Barkley & Associates, Inc. and will be held from May 25 - 26, 2019 at Palmer House a Hilton Hotel, Chicago, Illinois, United States of America. This CME Conference has been approved for a maximum of 16.25 Contact Hours of Continuing Education . Conference Topics: • Clinical Assessment • Common Problems in Acute Care • Diagnosis and Clinical Management for Adults • Extensive Review of System-Specific Health Problems • Health Care Delivery and Health Care Systems • Health Promotion and Disease Prevention • Nurse Practitioner/Patient Relationship • Pharmacologic management • Professional Role Additional details will be posted as soon as they are available.
May 30 - Jun 02, 2019 | CME 31.00 | Rosemont, Illinois
Trauma Basic Principles is organized by AO North America and will be held from May 30 - Jun 02, 2019 at Hyatt Regency O'Hare, Rosemont, Illinois, United States of America. Course Summary: This Basic Course is designed to provide the participant with a fundamental knowledge of operative treatment of fractures according to the AO principles. The four guiding AO principles of fracture fixation are: • Anatomic reduction of the fracture fragments, particularly in joint fractures • Stable fixation to ensure proper healing of the fracture allowing surrounding tissue to move and strengthen • Atraumatic surgical technique to preserve the blood supply to the bone fragments and soft tissue • Early, pain-free mobilization returning the patient to function as soon as possible. The course will cover the concepts of absolute and relative stability, as applied in context, of the soft tissue injury for each limb segment’s major fracture types. This course is the foundation for the AONA curriculum, which teaches the surgeon how to manage trauma and trauma reconstruction. The goal of this course is not to advocate the treatment of all fractures by surgical fixation, but rather to help ensure that when surgery is carried out, that it is done properly based upon principles, appropriate preoperative planning, and decision making. Learning Objectives: Upon completion, participants should be able to: • Discuss the concepts of stability, their influence on bone healing, and how to apply implants to achieve appropriate stability • Plan a treatment based on assessment, imaging, classification, and decision making • Apply reduction techniques in fracture management with attention to the importance of the soft-tissue • Apply related psychomotor skills to the practical application of orthopedic implants to fractured bones • Plan the initial treatment of the polytraumatized patient Additional details will be posted as soon as they are available.
May 30 - Jun 01, 2019 | CME 22.50 | Glenview, Illinois
Advanced Critical Care Echocardiography is organized by American College of Chest Physicians (ACCP) and will be held from May 30 - Jun 01, 2019 at American College-Chest Physicians, Glenview, Illinois, United States of America. Target Audience: Intensivists, critical care and emergency medicine physicians, pulmonary and critical care fellows, and advanced practice providers are encouraged to attend. Candidates for the NBE ACCE certification will be particularly interested in this unique CHEST course offering. Accreditation: Physician Credit: CHEST designates this live activity for a maximum of 22.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ABIM MOC Statement Successful completion of this CME activity enables the participant to earn up to 22.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Nursing Credit Provider approved by the California Board of Registered Nursing, Provider Number 16433, for 22.5 contact hours. Description: This course is designed to meet the needs of all critical care clinicians who are interested in ACCE; and, in particular, for those who are candidates for Certification in Advanced Critical Care Echocardiography,now offered by the National Board of Echocardiography (NBE) in cooperation with the National Board of Medical Examiners and the Professional Societies.This course will focus on image acquisition and image interpretation,which are required competences to achieve NBE certification. CHEST also offers a separate review course in preparation for the NBE certification examination in December 2019. Work with expert-level faculty to gain interactive image interpretation skills through the review of a broad spectrum of findings of advanced critical care echocardiography (ACCE), with emphasis on frontline utility of ACCE for the diagnosis and management of cardiopulmonary failure. Learn to integrate findings of ACCE into clinical operations by using: • Doppler physics • Measurement of stroke volume/cardiac output (SV/CO) • Detailed assessment of LV and RV function • Measurement of filling pressures and diastolic function • Evaluation of valve function • Determination of preload sensitivity • Measurement of intracardiac pressures • Identification of adverse heart-lung interactions Prerequisites This course is designed for intensivists who are fully proficient in basic critical care echocardiography and are strongly committed to precourse cognitive preparation. Didactic lectures will not be presented. Instead, attendees will be expected to engage in a serious study of the pre-course material provided, as this course is designed for those who have completed the recommended reading. Prior to attending, you will receive materials that form the cognitive base of the course. We anticipate thatyou will be thoroughly familiar with the content prior to starting the course in order to reduce the need for lectures, so the focus can be on hands-on, interactive training.
May 31, 2019 | CME 2.00 | Free | Chicago, Illinois
Strategies to Maximize the Clinical Benefit of EGFR TKIs in Advanced NSCLC (May 2019) is organized by Clinical Care Options (CCO), LLC and will be held on May 31, 2019 at Sheraton Grand Chicago, Chicago, Illinois, United States of America. Target Audience: This program is intended for physicians, oncology nurses, pharmacists, and other healthcare providers who care for patients with non-small-cell lung cancer. Accreditation: Physician Continuing Medical Education: The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Continuing Education: The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours. Pharmacist Continuing Education: Credit Designation: Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education. Goal Statement: The goal of this activity is to improve participants’ knowledge of and competence in applying EGFR inhibitors in the treatment of patients with EGFR-mutated non-small-cell lung cancer. Learning Objectives: • Apply expert recommendations for frontline therapy for advanced EGFR-mutated NSCLC focusing on safety, efficacy, and the individualization of therapy based on tumor-specific and patient-specific factors • Compare the efficacy and safety of first-generation EGFR TKIs with later-generation EGFR TKIs • Examine current recommendations for molecular testing and the roles for liquid biopsies in guiding the use of EGFR TKI therapy • Plan optimal sequencing of EGFR TKIs after considering the available evidence and expert recommendations • Evaluate current and evolving treatment approaches to address acquired resistance and progression in advanced EGFR-mutated NSCLC
May 31, 2019 | CME 2.00 | Free | Chicago, Illinois
An Evening With Experts: Selecting and Sequencing Therapy in HR+/HER2- Metastatic Breast Cancer is organized by Clinical Care Options (CCO), LLC and will be held on May 31, 2019 at Sheraton Grand Chicago, Chicago, Illinois, United States of America. This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits™. Target Audience: This program is intended for oncologists and other allied healthcare professionals caring for patients with metastatic breast cancer receiving targeted therapy. Goal Statement: The goal of this activity is to improve the knowledge, confidence, and competence of oncology specialists and other clinicians caring for their patients with MBC receiving CDK4/6 inhibitors, mTOR inhibitors, PI3K inhibitors, and promising investigational agents. Learning Objectives: • Evaluate current guidelines and current/emerging clinical trial data on everolimus, palbociclib, palbociclib, and abemaciclib (in addition to others under clinical investigation) to aid in the refinement of current treatment algorithms for patients with de novo or recurrent HR-positive/HER2-negative MBC • Describe current therapeutic strategies and ongoing clinical trials of targeted therapy–based combinations for both early-stage and HR-positive, HER2-negative MBC • Identify ongoing trials investigating novel treatment options after disease progression on endocrine and/or CDK4/6 inhibitor-based therapy to aid in clinical trial participation Additional details will be posted as soon as they are available.
Motor Control - Enhancing Functional Movement Through Central Nervous System Neuroplastic Change - Aurora, Illinois
Jun 01 - 02, 2019 | CME 18.00 | USD $425 | Aurora, Illinois
Motor Control - Enhancing Functional Movement Through Central Nervous System Neuroplastic Change is organized by Health Click and will be held from Jun 01 - 02, 2019 at Rush Copley Medical Center, Aurora, Illinois, United States of America. The target audience for this medical event is for PT, PTA, OT, OTA, AT. This CME Conference has been approved for a maximum of 18 hours of CME credits. CME : This CME Conference has been approved for a maximum of 18.0 contact hours/1.80 CEU’s for therapists licensed in District of Columbia, New York, or Illinois. Conference Description : This two-day advanced course will systematically encourage critical thinking of how a therapist might carefully consider each patient’s unique parameters that will allow him or her to learn (or re-learn) motor control through central nervous system neuroplastic change. The course will explore the connection between neuroscience and clinical outcomes in a tangible manner such that meaningful progress can be achieved. Goal setting, measuring progress and addressing funding concerns will also be discussed in detail. Unique pediatric, adult and geriatric challenges will be discussed with respect to creating the best possible outcomes. Discussion of outcome measure selection with consideration to the patient’s diagnosis and age will help the clinician follow, progress and formulate evidence-based strategies; as well as justify the need for therapeutic intervention within today’s health care funding parameters. A focus on implementing family-centered care will also be an important topic in this course. This course will prepare PT’s, PTA’s and OT’s to objectively manage the neurologically involved client in a manner that will maximize their functional movement. Conference Objectives are : • Demonstrate understanding of neuroplasticity applied to patients with neurological impairment at any age. • Demonstrate understanding of various motor control theories and select valid concepts toward developing an effective plan of care for the patient with neurological impairment. • Identify sensorimotor impairments and effective therapeutic interventions based on video case studies. • Develop programs that enhance movement therapy strategies including task-specific training, activity based strengthening, and the benefits of neuromuscular reeducation across the life span with consideration of unique diagnostic and patient characteristics. • Identify unique characteristics within specific diagnostic groups that require special attention for developing motor learning. • Identify the secondary effects of abnormalities of tone and posture. • Perform outcome tests and measures that are reliable in assessing the level of recovery for the patient with neurological impairment at any age. • Identify important documentation elements toward insuring funding for necessary therapy intervention. • Discuss current healthcare legislation and the impact on family centered care. • Identify key evaluation and treatment techniques to enhance lasting function in a value-based accountability system. Additional details will be posted as soon as they are available.
Jun 01, 2019 | CME 2.00 | Free | Chicago, Illinois
B-Cell Malignancies - Expert Guidance on BTK Inhibitors for Today’s Clinic is organized by Clinical Care Options (CCO), LLC and will be held on Jun 01, 2019 at Sheraton Grand Chicago, Chicago, Illinois, United States of America. This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits™. Target Audience This program is intended for hematologists, hematologist-oncologists, and other clinicians involved in the management of patients with MCL, CLL, and other B-cell malignancies. Goal Statement The goal of this activity is to improve participants’ competence in using BTK inhibitors to improve treatment outcomes for patients with B-cell malignancies. Learning Objectives • Evaluate differences among agents targeting BTK in terms of molecular characteristics, preclinical data, approved indications, dosing, safety profile, and efficacy • Consider existing and emerging clinical research data evaluating currently available and emerging BTK inhibitors (and BTK-based combinations) in the formulation of therapeutic recommendations for patients with MCL, CLL, and other B-cell malignancies • Recognize and manage adverse events and toxicities associated with BTK inhibitor therapy to support quality of life and continuation of treatment • Explain to patients the importance of and provide strategies for optimal adherence to prescribed BTK inhibitors • Assess ongoing clinical trials evaluating currently available and emerging BTK inhibitors (and BTK-based combinations) to aid clinical trial enrollment and predict new options in the clinic Additional details will be posted as soon as they are available.
Jun 01, 2019 | CME 2.00 | Free | Chicago, Illinois
PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application and Genetic Testing is organized by Clinical Care Options (CCO), LLC and will be held on Jun 01, 2019 at Radisson Blu Aqua Hotel, Chicago, Chicago, Illinois, United States of America. Target Audience: This program is intended for physicians, nurses, pharmacists, and other healthcare providers who care for patients with metastatic breast cancer. Accreditation: Physicians: NCCN designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses: NCCN designates this educational activity for a maximum of 2.0 contact hours. Pharmacists: NCCN designates this knowledge-based continuing education activity for 2.0 contact hours (0.2 CEUs) of continuing education credit. Goal Statement: The goal of this activity is to improve participants’ knowledge of, confidence in, and competence in integrating PARP inhibitors into treatment of patients with breast cancer. Learning Objectives: • Describe the mechanism of action of the different PARP inhibitors and the rationale for PARP inhibition in treating metastatic breast cancer • Identify patients based on molecular changes and previous therapy that are most likely to benefit from treatments with PARP inhibitors • Integrate single-agent PARP inhibitors into the treatment of appropriately selected patients with metastatic breast cancer •Refer eligible patients with metastatic breast cancer to clinical trials of single-agent PARP inhibitors and combinations of PARP inhibitors with other anticancer therapies Additional details will be posted as soon as they are available.
Jun 02 - 07, 2019 | CME 48.00 | USD $1645 | Schaumburg, Illinois
Internal Medicine Board Review (IMBR) Courses is Organized by American College of Physicians (ACP) and will be held from Jun 02 - 07 2019 at Renaissance Schaumburg Convention Center Hotel, Chicago, Illinois, United States of America. CME Accreditation: The American College of Physicians designates this live activity for a maximum of 48 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. MOC Information: Successful completion of this CME activity, which include participation in the evaluation component, enables the participant to earn up to 48 MOC points in medical knowledge in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. ACP's IMBR Courses Provide: • A comprehensive review of internal medicine that is guided by the blueprint of the ABIM Board exam • Interactive case-based studies for an engaging learning experience • Tips on test-taking strategies to strengthen your confidence • Instruction by a team of expert clinician-educators • ACP Digital Flashcards • Electronic Syllabus available for download • Earn CME Credits and MOC Points • Guaranteed to prepare you for the ABIM board exam Course Objectives : • Increase and refresh knowledge of core topics in internal medicine and the subspecialties through discussion of common and not-so-common clinical problems. • Become adept working through difficult test questions logically and successfully. • Implement changes in clinical practice in accordance with recent advances and clinical guidelines. Additional details will be posted as soon as they are available.
Jun 02 - 06, 2019 | AMA PRA Ca 50.00 | USD $1058 | Chicago, Illinois
Ophthalmology Oral Lectures Course is organized by The Osler Institute and will be held from Jun 02 - 06, 2019 at Holiday Inn & Suites Chicago North Shore (Skokie), Chicago, Illinois, United States of America. This Course has been approved for a maximum of 50 AMA PRA Category 1 Credit(s)™. Optional extra day of Mock Orals (June 7): Designation: The Osler Institute designates this optional Live activity for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Participants receive one complimentary 30 min public Mock Oral session with registration for the extra day. Participants and faculty meet face-to-face in a half-hour simulation of the oral board process followed by faculty critique. When not participating in your own public Mock Oral exam you will have the opportunity to view the public sessions of other participants. Learn by doing and observing others. Enter Mock Oral topic preference in the indicated box when registering. Course Description: This five-day course includes presentations that review the entire field of Ophthalmology using both a didactic lecture approach as well as case-based reviews. Emphasis is on evidence-based medicine and board-relevant standard of care. As a result, the course provides the perfect review for the ABO oral certification exam as well as a good overall review for the DOCK exam or for physicians in practice. Many of our previous participants found the course provided them with improved diagnostic and evaluation skills and helped them recognize specific areas of weakness for self-study. The course includes lectures with a complimentary searchable e-syllabus (PDFs of all PowerPoint presentations) as well as mock oral exams to observe without charge (June 5 and 6). Additional details will be posted as soon as they are available.